How do you differentiate between endogenous and exogenous Cushing's syndrome in a patient presenting with symptoms of Cushing's syndrome?

Differentiating Endogenous from Exogenous Cushing's Syndrome

The critical first step is obtaining a detailed medication history to identify any glucocorticoid exposure—including oral, inhaled, injectable, topical, or intranasal corticosteroids—as exogenous Cushing's syndrome is the most common cause and must be ruled out before pursuing an endogenous workup 1, 2, 3.

Initial Clinical Distinction

Medication History Assessment

• Systematically review all potential sources of exogenous glucocorticoids, including:

  • Oral prednisone, methylprednisolone, or dexamethasone 1
  • Inhaled corticosteroids (budesonide, fluticasone), particularly when combined with azole antifungals which dramatically increase systemic absorption 1
  • Injectable depot steroids for joint or soft tissue injections 1
  • Topical glucocorticoid preparations on large body surface areas 1
  • Intranasal or ophthalmic steroid preparations 1

• If any exogenous glucocorticoid use is confirmed, the diagnosis is exogenous Cushing's syndrome, and no further biochemical testing for endogenous causes is needed 2, 3.

Biochemical Differentiation When History is Unclear

When Exogenous Sources Are Ruled Out

• Proceed with first-line screening tests for endogenous Cushing's syndrome using one or more of the following 4, 5, 3:
  • 24-hour urinary free cortisol (sensitivity 89-95%) 4
  • Late-night salivary cortisol 4, 5, 3
  • 1 mg overnight dexamethasone suppression test 4, 5, 3

ACTH Level: The Key Differentiator for Endogenous Causes

• Measure plasma ACTH concentration once endogenous hypercortisolism is confirmed 5, 2, 6, 3:
  • Suppressed ACTH (<5 pg/mL) indicates ACTH-independent disease (adrenal source: adenoma, carcinoma, or hyperplasia) 4, 2, 6
  • Mid-normal to elevated ACTH indicates ACTH-dependent disease (pituitary adenoma/Cushing's disease 60-70% of cases, or ectopic ACTH secretion) 4, 2, 6

Clinical Features That Suggest Endogenous vs Exogenous

Distinguishing Clinical Patterns

• Both endogenous and exogenous Cushing's present with similar features: central obesity, facial plethora, purple striae, easy bruising, proximal muscle weakness, hypertension (70-90%), and hyperglycemia (>80%) 4, 5, 2.

• Exogenous Cushing's typically has:

  • Clear temporal relationship between symptom onset and corticosteroid initiation 3
  • Suppressed ACTH levels (if measured) due to negative feedback 2
  • Risk of adrenal insufficiency upon abrupt discontinuation due to HPA axis suppression 1

• Endogenous Cushing's typically has:

  • Insidious onset without medication exposure 5, 3
  • Progressive worsening over months to years 4
  • Average diagnostic delay of 3 years from symptom onset 4

Algorithmic Approach

Step 1: Medication History

• If exogenous glucocorticoids identified → Diagnosis is exogenous Cushing's syndrome 1, 2, 3
• If no exogenous sources → Proceed to Step 2

Step 2: Screen for Hypercortisolism

• Perform 24-hour urinary free cortisol, late-night salivary cortisol, or 1 mg dexamethasone suppression test 4, 5, 3
• If screening tests normal → Not Cushing's syndrome
• If screening tests abnormal → Proceed to Step 3

Step 3: Measure ACTH

• ACTH suppressed (<5 pg/mL) → Adrenal imaging with CT or MRI to identify adrenal source 6, 3
• ACTH mid-normal to elevated → Pituitary MRI and consider high-dose dexamethasone suppression test or bilateral inferior petrosal sinus sampling to distinguish pituitary from ectopic sources 2, 7, 6, 3

Common Pitfalls to Avoid

• Do not assume all Cushing's syndrome is exogenous even in patients on corticosteroids—they can have concurrent endogenous disease 1.

• Do not overlook inhaled corticosteroids, especially when combined with azole antifungals (itraconazole, voriconazole), as this combination significantly increases systemic absorption and risk of iatrogenic Cushing's 1.

• Do not miss topical corticosteroid overuse on large body surface areas or under occlusive dressings, which can cause systemic absorption 1.

• Do not forget that exogenous Cushing's requires gradual glucocorticoid tapering rather than abrupt discontinuation to prevent life-threatening adrenal crisis 1, 5.